IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.
about
Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination StudiesPediatric Sarcoma Data Forms a Unique Cluster Measured via the Earth Mover's Distance.Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer.Pediatric Development of Molecularly Targeted Oncology Drugs.Modeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma.A review of soft-tissue sarcomas: translation of biological advances into treatment measures.
P2860
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.
description
2016 nî lūn-bûn
@nan
2016 թվականի օգոստոսի 30-ին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
name
IGF-1R and mTOR Blockade: Nove ...... ombinations for Ewing Sarcoma.
@en
type
label
IGF-1R and mTOR Blockade: Nove ...... ombinations for Ewing Sarcoma.
@en
prefLabel
IGF-1R and mTOR Blockade: Nove ...... ombinations for Ewing Sarcoma.
@en
P2093
P2860
P356
P1476
IGF-1R and mTOR Blockade: Nove ...... ombinations for Ewing Sarcoma.
@en
P2093
Adriana S Buford
Alexander J Lazar
Antonios G Mikos
Brian A Menegaz
Deeksha Vishwamitra
Eric M Rohren
Hesham M Amin
Izabela Fokt
Joseph A Ludwig
P2860
P356
10.1093/JNCI/DJW182
P407
P50
P577
2016-08-30T00:00:00Z